Author

Nuno M. Mendes

Universidade do PortoORCID 0000-0002-0570-2277Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Assay:CRISPR screen· 1 Organism:mouse· 1

Frequent Co-Authors

Raquel AlmeidaiD· 2 shared Alexandre Coelho· 1 shared Ana Luísa AmaraliD· 1 shared Ana Rita de Sousa Silva· 1 shared Bruno CavadasiD· 1 shared Bruno PereiraiD· 1 shared Carina Carvalho‐MaiaiD· 1 shared Carla OliveiraiD· 1 shared

Activity by Year

2018-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Raquel AlmeidaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Intestinal stem cell marker MEX3A regulates PPARγ expression with functional impact in colorectal carcinogenesis

Ana Rita de Sousa Silva, Alexandre Coelho, Vanessa Machado, Morgana Russel, Dalila de Jesus Lopes Mexieiro, Ana Luísa Amaral, Bruno Cavadas, Nuno M. Mendes, Carina Carvalho‐Maia, Davide Gigliano, Cármen Jerónimo, Raquel Almeida, Bruno Pereira

This study shows MEX3A regulates PPARγ expression in colorectal cancer, affecting tumor growth and chemotherapy response.

Cellular and Molecular Gastroenterology and Hepatology · Jan 1, 2026Peer-reviewedCancer Biology

CD44v6 expression is a novel predictive marker of therapy response and poor prognosis in gastric cancer patients

Carla Pereira, Daniel Ferreira, Carolina Lemos, Diana Martins, Nuno Mendes, Daniela Almeida, Pedro Granja, Fátima Carneiro, Raquel Almeida, Gabriela M Almeida, Carla Oliveira

This study identifies CD44v6 expression as a predictor of therapy response and poor prognosis in gastric cancer patients, showing higher expression correlates with worse outcomes and benefit from chemotherapy.

bioRxiv · Nov 30, 2018 · PreprintCancer Biology